2012
DOI: 10.1016/j.febslet.2012.07.040
|View full text |Cite
|
Sign up to set email alerts
|

Structural and functional characterization of the bacterial translocation inhibitor GE82832

Abstract: a b s t r a c tThe structure of GE82832, a translocation inhibitor produced by a soil microorganism, is shown to be highly related to that of dityromycin, a bicyclodecadepsipeptide antibiotic discovered long ago whose characterization had never been pursued beyond its structural elucidation. GE82832 and dityromycin were shown to interfere with both aminoacyl-tRNA and mRNA movement and with the Pi release occurring after ribosome-and EF-G-dependent GTP hydrolysis. These findings and the unusual ribosomal locali… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0

Year Published

2013
2013
2016
2016

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 23 publications
(32 citation statements)
references
References 38 publications
0
32
0
Order By: Relevance
“…Indeed, screening systems to identify compounds that preferentially inhibit the initiation phase have proved successful [51,52,53]. In addition, our IF3 DL -30S reporter assay can provide novel aspects of the inhibiting mechanism of known 30S-binding drugs.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, screening systems to identify compounds that preferentially inhibit the initiation phase have proved successful [51,52,53]. In addition, our IF3 DL -30S reporter assay can provide novel aspects of the inhibiting mechanism of known 30S-binding drugs.…”
Section: Discussionmentioning
confidence: 99%
“…Meanwhile, several lines of evidence suggest that a large scale conformational change of EF-G occurs during translocation (Agrawal et al, 1999; Bulkley et al, 2014; Munro et al, 2010; Salsi et al, 2014; Stark et al, 2000; Wang et al, 2007), including a recent study of the antibiotic dityromycin (Bulkley et al, 2014). Dityromycin was shown to block EF-G-mediated tRNA translocation without affecting the binding of EF-G to the ribosome (Brandi et al, 2006; Brandi et al, 2012). The crystal structure of dityromycin in complex with the ribosome shows that dityromycin binds to ribosomal protein S12 (Bulkley et al, 2014), a position that would severely overlap with domain III of EF-G in the elongated form, thereby indicating the necessity for substantial domain rearrangements in EF-G on the PRE ribosome.…”
Section: Introductionmentioning
confidence: 99%
“…The antibiotic dityromycin has also been shown to block EF-G associated translocation 107 . The crystal structure of dityromycin in complex with the ribosome reveals that it binds to ribosomal protein S12 and would clash with domain III of EF-G in its elongated form 108 (Fig.…”
Section: Structural Comparison Of Isolated Ef-g Ef4 and Bipamentioning
confidence: 99%